Cherrymount Healthcare Limited iXBRL


Relate AccountsProduction v2.3.1 v2.3.1 2018-03-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the company is that of retail pharmacy. 26 June 2019 42 46 NI027072 2019-02-28 NI027072 2018-02-28 NI027072 2017-02-28 NI027072 2018-03-01 2019-02-28 NI027072 2017-03-01 2018-02-28 NI027072 uk-bus:PrivateLimitedCompanyLtd 2018-03-01 2019-02-28 NI027072 uk-bus:AbridgedAccounts 2018-03-01 2019-02-28 NI027072 uk-core:ShareCapital 2019-02-28 NI027072 uk-core:ShareCapital 2018-02-28 NI027072 uk-core:RetainedEarningsAccumulatedLosses 2019-02-28 NI027072 uk-core:RetainedEarningsAccumulatedLosses 2018-02-28 NI027072 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2019-02-28 NI027072 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2018-02-28 NI027072 uk-bus:FRS102 2018-03-01 2019-02-28 NI027072 uk-core:LandBuildings 2018-03-01 2019-02-28 NI027072 uk-core:FurnitureFittingsToolsEquipment 2018-03-01 2019-02-28 NI027072 uk-core:MotorVehicles 2018-03-01 2019-02-28 NI027072 uk-core:Goodwill 2018-03-01 2019-02-28 NI027072 uk-core:Goodwill 2018-02-28 NI027072 uk-core:Goodwill 2019-02-28 NI027072 2018-03-01 2019-02-28 NI027072 uk-bus:Director1 2018-03-01 2019-02-28 NI027072 uk-bus:AuditExempt-NoAccountantsReport 2018-03-01 2019-02-28 xbrli:pure iso4217:GBP xbrli:shares
 
 
 
 
 
 
 
Company Number: NI027072
 
 
Cherrymount Healthcare Limited
 
Unaudited Abridged Financial Statements
 
for the year ended 28 February 2019
Cherrymount Healthcare Limited
Company Number: NI027072
ABRIDGED BALANCE SHEET
as at 28 February 2019

2019 2018
Notes £ £
 
Fixed Assets
Intangible assets 4 1,773,183 2,302,596
Tangible assets 5 102,591 90,981
───────── ─────────
1,875,774 2,393,577
───────── ─────────
 
Current Assets
Stocks 523,298 523,362
Debtors 816,757 503,643
Cash and cash equivalents 664,175 1,006,753
───────── ─────────
2,004,230 2,033,758
───────── ─────────
Creditors: Amounts falling due within one year (1,133,128) (1,226,723)
───────── ─────────
Net Current Assets 871,102 807,035
───────── ─────────
Total Assets less Current Liabilities 2,746,876 3,200,612
 
Creditors
Amounts falling due after more than one year (1,912,134) (2,040,924)
 
Provisions for liabilities (4,532) (2,710)
 
Government grants (184) (210)
───────── ─────────
Net Assets 830,026 1,156,768
═════════ ═════════
Capital and Reserves
Called up share capital 6 6
Profit and Loss Account 830,020 1,156,762
───────── ─────────
Equity attributable to owners of the company 830,026 1,156,768
═════════ ═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
           
All of the members have consented to the preparation of abridged accounts in accordance with section 444(2A) of the Companies Act 2006.
           
The company has taken advantage of the exemption under section 444 not to file the Abridged Profit and Loss Account and Directors' Report.
           
For the financial year ended 28 February 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
           
The directors confirm that the members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 of the Companies Act 2006.
           
The directors acknowledge their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
           
Approved by the Board and authorised for issue on 26 June 2019 and signed on its behalf by
           
           
________________________________          
Mr. Sheelin McKeagney          
Director          



Cherrymount Healthcare Limited
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
for the year ended 28 February 2019

   
1. GENERAL INFORMATION
 
Cherrymount Healthcare Limited is private company limited by shares incorporated in Northern Ireland. The principle place of business and registered office is 10 Edward Street, Lurgan, Craigavon, Co Armagh, BT66 6DB. The Financial statements are presented in pounds sterling (£) which is also the functional currency of the company. The company registeration number is NI027072.
         
2. ACCOUNTING POLICIES
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the year ended 28 February 2019 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
Cash flow statement
The company has availed of the exemption in FRS 102 Section 1A from the requirement to prepare a Cash Flow Statement because it is classified as a small company.
 
Turnover
Turnover represents the total invoice value, excluding value added tax, of sales made during the year. Revenue is recognised upon customer receipt.
 
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost  less accumulated depreciation. The charge to depreciation is calculated to write off the original cost of tangible fixed assets, less their estimated residual value, over their expected useful lives as follows:
 
  Land and buildings freehold - 2% Straight line
  Fixtures, fittings and equipment - 20% Reducing Balance
  Motor vehicles - 25% Straight Line
 
The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
 
Goodwill
Purchased goodwill arising on the acquisition of a business represents the excess of the acquisition cost over the fair value of the identifiable net assets including other intangible fixed assets when they were acquired. Purchased goodwill is capitalised in the Balance Sheet and amortised on a straight line basis over its economic useful life of 10 years, which is estimated to be the period during which benefits are expected to arise.  On disposal of a business any goodwill not yet amortised is included in determining the profit or loss on sale of the business.
 
Stocks
Stocks are valued at the lower of cost and net realisable value.  Cost comprises expenditure incurred in the normal course of business in bringing stocks to their present location and condition.  Full provision is made for obsolete and slow moving items.  Net realisable value comprises actual or estimated selling price (net of trade discounts) less all further costs to completion or to be incurred in marketing and selling.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Borrowing costs
Borrowing costs relating to the acquisition of assets are capitalised at the appropriate rate by adding them to the cost of assets being acquired. Investment income earned on the temporary investment of specific borrowings pending their expenditure on the assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.
 
Provisions
Provisions are recognised when the company has a present legal or constructive obligation arising as a result of a past event, it is probable that an outflow of economic benefits will be required to settle the obligation and a reliable estimate can be made. Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a pre-tax rate that reflects current market assessments of the same value of money and the risks specific to the obligation. The increase in the provision due to passage of time is recognised as interest expense.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Employee benefits
The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The company also operates a defined benefit pension scheme for its employees providing benefits based on final pensionable pay. The assets of this scheme are also held separately from those of the company, being invested with pension fund managers.
 
Taxation and deferred taxation
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
 
Government grants
Capital grants received and receivable are treated as deferred income and amortised to the Profit and Loss Account annually over the useful economic life of the asset to which it relates. Revenue grants are credited to the Profit and Loss Account when received.
 
Share capital of the company
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
       
3. EMPLOYEES
 
The average monthly number of employees, including directors, during the year was 0.00|0, (2018 - 46).
 
  2019 2018
  Number Number
 
Employees 42 46
  ═════════ ═════════
       
4. INTANGIBLE FIXED ASSETS
     
  Goodwill Total
  £ £
Cost
At 1 March 2018 5,601,039 5,601,039
  ───────── ─────────
 
At 28 February 2019 5,601,039 5,601,039
  ───────── ─────────
Amortisation
At 1 March 2018 3,298,443 3,298,443
Charge for year 529,413 529,413
  ───────── ─────────
At 28 February 2019 3,827,856 3,827,856
  ───────── ─────────
Net book value
At 28 February 2019 1,773,183 1,773,183
  ═════════ ═════════
At 28 February 2018 2,302,596 2,302,596
  ═════════ ═════════
           
5. TANGIBLE FIXED ASSETS
  Land and Fixtures, Motor Total
  buildings fittings and vehicles  
  freehold equipment    
  £ £ £ £
Cost
At 1 March 2018 84,000 170,325 - 254,325
Additions - 3,768 14,500 18,268
  ───────── ───────── ───────── ─────────
At 28 February 2019 84,000 174,093 14,500 272,593
  ───────── ───────── ───────── ─────────
Depreciation
At 1 March 2018 8,960 154,384 - 163,344
Charge for the year 1,680 3,529 1,449 6,658
  ───────── ───────── ───────── ─────────
At 28 February 2019 10,640 157,913 1,449 170,002
  ───────── ───────── ───────── ─────────
Net book value
At 28 February 2019 73,360 16,180 13,051 102,591
  ═════════ ═════════ ═════════ ═════════
At 28 February 2018 75,040 15,941 - 90,981
  ═════════ ═════════ ═════════ ═════════